Skip to main content

Advertisement

Table 1 Analysis of comments on uncertainty in NICE appraisals of cancer drugs

From: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals

  1. FAD: Final Appraisal Document AEs: adverse events
  2. FADs published January 2014–March 2016